Ambo Agritec Limited failed to file its financial results for the year ended March 31, 2026, within the timeline prescribed by Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The delay was caused by the sudden illness of the company's Chief Financial Officer, who plays a key role in finalizing, reviewing, and certifying the financial statements. The executive was suffering from high fever and cough and was medically advised to take complete bed rest for five days.

The unavailability of the CFO due to this medical condition led to an unavoidable postponement of the financial closing process, internal review, and coordination required to place the results before the Board of Directors. Consequently, the submission to the stock exchange was delayed. The company clarified that the delay was unintentional and resulted from circumstances beyond its control.

Ambo Agritec has since completed the necessary steps and filed the financial results at the earliest possible date. In a communication to BSE Limited, the company expressed regret for the delay and affirmed its commitment to ensuring full compliance with all applicable regulatory requirements.

To prevent future occurrences, the company stated that it is taking necessary steps to strengthen internal processes. The explanation was submitted to the exchange on June 22, 2026, by Umesh Kumar Agarwal, Managing Director of Ambo Agritec Limited.

Ambo Agritec Limited has reported a net profit of ₹251.44 lakh for the financial year ended March 31, 2026, compared to ₹190.74 lakh in the previous year. Revenue from operations for the year stood at ₹12,971.52 lakh, up from ₹12,001.99 lakh in FY25. The Board of Directors approved the audited standalone financial results at its meeting held on June 4, 2026.

The statutory audit report with an unmodified opinion was issued by M/s. Dokania S. Kumar & Co., Statutory Auditors of the company. The report confirms that the standalone annual financial results give a true and fair view of the company's financial position in conformity with the applicable accounting standards. The consolidated financial results for the year reported a profit after tax of ₹49.16 lakh, attributable to equity shareholders of the company.

Financial Performance

The company's total income for FY26 increased to ₹12,975.14 lakh from ₹12,211.08 lakh in the previous year. Total expenses for the period rose to ₹12,622.74 lakh. Earnings per equity share (basic and diluted) for the year were ₹1.37, compared to ₹1.72 in the prior year. The half-year ended March 31, 2026, recorded a profit after tax of ₹31.27 lakh.

Segment Performance

The Trading segment generated the highest revenue at ₹9,932.10 lakh, followed by Manufacturing at ₹3,004.20 lakh and Services at ₹35.22 lakh. The Trading segment also reported the highest segment results at ₹247.59 lakh. The company's total assets as of March 31, 2026, stood at ₹9,550.30 lakh, compared to ₹6,761.13 lakh in the previous year.